French drugmaker Sanofi and its British partner GlaxoSmithKline said on Wednesday they intend to submit data from their booster and Phase III efficacy trials as the basis for regulatory applications…

Read more »

The post Sanofi, GSK to Seek COVID-19 Vaccine Candidate Approval appeared first on Hamodia.

In related news:

  1. Britain Starts Accelerated Review for AstraZeneca’s Potential COVID-19 Vaccine
  2. T-Cell Study Adds to Debate Over Duration of COVID-19 Immunity
  3. ‘One Village, One Policy’: China Keeps It Local to Battle COVID Wave
  4. WHO Estimates COVID-19 Boosters Needed Yearly for Most Vulnerable
  5. Omicron Cases at Much Lower Risk of Hospital Admission, U.K. Says